matrigel

commercially available product which consists of 60% laminin, 30% type 4 collagen, 5% nidogen, 3% heparin sulfate proteoglycan & 1% entactin; promotes neurite outgrowth in culture

Also Known As:

Matrigel

Pharmalogical Action Categories:

D001672 - Biocompatible Materials

Macromolecular Substances: 97
- Polymers: 13529
  - Biopolymers: 836
    - Collagen: 53775
      - matrigel: 3072
Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Glycoproteins: 25180
    - Proteoglycans: 4882
      - matrigel: 3072
    - Membrane Glycoproteins: 2277
      - Laminin: 4750
        matrigel: 3072
  - Membrane Proteins: 10262
    - Membrane Glycoproteins: 2277
      - Laminin: 4750
        matrigel: 3072
  - Scleroproteins: 75
    - Extracellular Matrix Proteins: 3213
      - Collagen: 53775
        matrigel: 3072
      - Laminin: 4750
        matrigel: 3072
Pharmaceutical Preparations
- Drug Combinations: 5500
  - matrigel: 3072
Carbohydrates: 22516
- Polysaccharides: 15996
  - Proteoglycans: 4882
    - matrigel: 3072
- Glycoconjugates: 1370
  - Glycoproteins: 25180
    - Proteoglycans: 4882
      - matrigel: 3072
    - Membrane Glycoproteins: 2277
      - Laminin: 4750
        matrigel: 3072

Yasmine Ziat Selected Research

Yasmine Ziat Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure